Nell-1-induced bone regeneration in calvarial defects.
Tara Aghaloo1, Catherine M Cowan, Yu-Fen Chou
1Dental and Craniofacial Research Institute, Department of Bioengineering, School of Dentistry, University of California, Los Angeles, 10833 Le Conte Ave., CHS 30-117, Los Angeles, CA 90095, USA.
The American Journal of Pathology
|August 29, 2006
Summary
NELL-1 is a novel molecule that promotes bone regeneration. This study shows NELL-1 can be a therapeutic alternative for bone defects, stimulating osteogenesis and bone formation.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Craniofacial Biology
Background:
- Craniofacial birth defects often involve skeletal issues necessitating bone grafting.
- NELL-1, a novel secreted osteogenic molecule, was previously identified and found to be overexpressed in craniosynostosis.
- NELL-1 overexpression enhances osteoblast differentiation and mineralization, and promotes premature bone formation in mice.
Purpose of the Study:
- To investigate the role of NELL-1 in osteogenesis and bone regeneration.
- To explore the regulatory pathways influencing NELL-1 expression.
- To evaluate the therapeutic potential of NELL-1 in bone defect repair.
Main Methods:
- Analysis of calvarial explants from Nell-1 transgenic mice.
- Gene expression analysis of osteoblasts treated with NELL-1.
- In vivo studies using NELL-1 protein-coated scaffolds in rat calvarial defects.
Main Results:
- NELL-1 overexpression in explants led to continuous bone growth and suture overlap.
- NELL-1 modulated osteogenic gene expression, reducing early markers and inducing later ones.
- NELL-1 promoted bone regeneration in rat calvarial defects, comparable to BMP-2, and altered cellular expression profiles.
Conclusions:
- NELL-1 plays a significant role in regulating osteogenesis and bone formation.
- Fibroblast growth factor-2 and transforming growth factor-beta1 stimulate NELL-1 expression.
- NELL-1 demonstrates therapeutic potential as an alternative to current bone grafting techniques.
